Stock OGN ORGANON & CO.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies Organon & Co.

Equities

OGN

US68622V1061

Market Closed - Nyse
Other stock markets
 04:00:02 2024-06-14 pm EDT 		5-day change 1st Jan Change
20.4 USD -0.54% Intraday chart for Organon & Co. -1.69% +41.47%
May. 24 Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation MT
May. 24 Shanghai Henlius Biotech, Inc. and Organon Announces That the European Medicines Agency Has Validated the Marketing Authorization Applications for Hlx14 CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OGN Stock
  4. News Organon & Co.
  5. MarketScreener Strategies